| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,038 |
4,245 |
$156K |
| 87428 |
|
521 |
492 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
347 |
321 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
415 |
372 |
$14K |
| 85027 |
|
2,362 |
2,186 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
953 |
737 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
47 |
45 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
157 |
78 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
180 |
180 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
15 |
$832.50 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
59 |
58 |
$622.45 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
42 |
42 |
$356.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
700 |
616 |
$330.49 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
29 |
13 |
$330.00 |
| 81003 |
|
89 |
83 |
$117.68 |
| S8301 |
Infection control supplies, not otherwise specified |
13 |
12 |
$23.67 |
| 99051 |
|
1,336 |
1,218 |
$0.00 |
| 99072 |
|
3,407 |
2,889 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
75 |
62 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
48 |
46 |
$0.00 |
| 36416 |
|
1,878 |
1,728 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
468 |
450 |
$0.00 |
| 1000F |
|
18 |
18 |
$0.00 |